Plain-English translation of NCT06805045 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether using virtual and augmented reality technology during rectal cancer surgery can help surgeons operate more precisely and achieve better results. Rectal cancer surgery is complex, and even with current best practices, cancer can sometimes return or patients can experience side effects. Researchers want to see if this advanced imaging technology — which creates a 3D virtual map of your anatomy during surgery — can help surgeons remove cancer more completely while protecting nearby nerves and tissues.
Rectal cancer surgery is one of the most challenging operations doctors perform, and despite improvements over the past 20 years, the cancer still comes back in some patients and side effects like loss of bladder or sexual function remain common. This trial exists to see whether virtual and augmented reality guidance can help surgeons be more precise, remove cancer more completely, and reduce these complications.
You likely qualify if…
You likely don't qualify if…
If you join the new treatment group, you will undergo rectal cancer surgery using the augmented reality guidance system — your surgical team will use special 3D imaging technology during your operation to help guide their work. The trial will compare your surgical outcomes (how completely the cancer was removed, whether the surgical margins are clear, and any complications) with outcomes from patients who had standard surgery between 2017 and 2023. You will be followed for your standard postoperative care, with researchers tracking your recovery, any side effects, and cancer recurrence over time.
AI-generated summary from trial data · Aug 14, 2026 · Not medical advice
Italy